Abstract
Purpose
Our primary endpoint is to determine the effect of L-glutamine Resource (Nestlé Healthcare Nutrition) in the prevention of induced enteritis after pelvic radiotherapy (RT).
Methods
We observed the incidence of diarrhoea during and after pelvic radiation therapy in patients receiving L-glutamine Resource (Nestlé Healthcare Nutrition) supplementation. To assess results, patients were stratified according to prior treatment (prior surgery and/or concomitant chemotherapy, or no prior or concomitant treatment).
Results
Incidence of diarrhoea observed is similar to published series in which glutamine is not administered. Grade 1 intestinal toxicity was observed in 4 patients (15.4%), grade 2 in 10 patients (38.4%) and grade 3 in 5 patients (19.2%). Mean dose of RT at the start of enteritis was 23.55 Gy (12–40). No grade 4 toxicity occurred and in 7 patients (27%) no toxicity was reported. No differences in toxicity incidence were observed between RT dose levels.
Conclusions
Administration of glutamine to patients during pelvic RT does not appear to prevent the incidence of enteritis (diarrhoea). No differences were observed between patients who underwent concomitant chemotherapy (where you would expect an increase in toxicity) and those who did not.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nout RA, Putter H, Jürgenliemk-Schulz IM et al (2009) Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol 27:3547–3556
Miller RC, Martenson JA, Sargent DJ et al (1998) Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma. Int J Radiat Oncol Biol Phys 41:593–598
Keefe DM, Schubert MM, Elting LS et al (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831
Hauer-Jensen M, Wang J, Boerma M et al (2007) Radiation damage to the gastrointestinal tract: mechanisms, diagnosis, and management. Curr Opin Support Palliat Care 1:23–29
Diestel CF, Marques RG, Lopes-Paulo F et al (2007) Role of L-glutamine and glycine supplementation on irradiated colonic wall. Int J Colorectal Dis 22:1523–1529
Erbil Y, Oztezcan S, Giriş M et al (2005) The effect of glutamine on radiation-induced organ damage. Life Sci 78:376–382
Campos FG, Waitzberg DL, Mucerino DR et al (1996) Protective effects of glutamine enriched diets on acute actinic enteritis. Nutr Hosp 11:167–177. Review
Yoshida S, Kaibara A, Ishibashi N et al (2001) Glutamine supplementation in cancer patients. Nutrition 17:766–768
Giriş M, Erbil Y, Oztezcan S et al (2006) The effect of heme oxygenase-1 induction by glutamine on radiation-induced intestinal damage: the effect of heme oxygenase-1 on radiation enteritis. Am J Surg 191:503–509
Salman B, Oguz M, Akmansu M et al (2007) Effect of timing of glutamine-enriched enteral nutrition on intestinal damage caused by irradiation. Adv Ther 24:648–661
Savarese DM, Savy G, Vahdat L et al (2003) Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 29:501–513. Review
Erbil Y, Oztezcan S, Giriş M et al (2005) The effect of glutamine on radiation-induced organ damage. Life Sci 78:376–382
Rosenthal DI, Trotti A (2009) Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 19:29–34. Review
Stokman MA, Spijkervet FK, Boezen HM et al (2006) Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res 85:690–700. Review
Cerchietti LC, Navigante AH, Lutteral MA et al (2006) Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 65:1330–1337
Huang EY, Leung SW, Wang CJ et al (2000) Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. Int J Radiat Oncol Biol Phys 46:535–539
Topkan E, Yavuz MN, Onal C et al (2009) Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters. Lung Cancer 63:393–399
Jazieh AR, Younas A, Safa M et al (2007) Phase I clinical trial of concurrent paclitaxel, carboplatin, and external beam chest irradiation with glutamine in patients with locally advanced nonsmall cell lung cancer. Cancer Invest 25:294–298
Algara M, Rodríguez N, Viñals P et al (2007) Prevention of radiochemotherapy-induced esophagitis with glutamine: results of a pilot study. Int J Radiat Oncol Biol Phys 69:342–349
Richards EW, Long CL, Pinkston JA et al (1992) The role of oral glutamine supplementation in the prevention of radiation-induced enterocolitis in prostate cancer patients. FASEB J 6:A1680 [abstr]
Daniele B, Perrone F, Gallo C et al (2001) Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut 48:28–33
Giralt J, Regadera JP, Verges R et al (2008) Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebocontrolled nutritional trial. Int J Radiat Oncol Biol Phys 71:1213–1219
Kozelsky TF, Meyers GE, Sloan JA et al (2003) Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol 21:1669–1674
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Membrive Conejo, I., Reig Castillejo, A., Rodríguez de Dios, N. et al. Prevention of acute radiation enteritis: efficacy and tolerance of glutamine. Clin Transl Oncol 13, 760–763 (2011). https://doi.org/10.1007/s12094-011-0729-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-011-0729-3